Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yufei Xiang

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|April 8, 2022
GAD65 Antibody Epitopes and Genetic Background in Latent Autoimmune Diabetes in Youth (LADY)Yiman Peng, Xia Li, Yufei Xiang, et al.
Science Advances|May 27, 2021
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low dosesSham Nambulli, Yufei Xiang, Natasha L Tilston-Lunel, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low dosesSham Nambulli, Yufei Xiang, Natasha L Tilston-Lunel, et al.
Diabetes, Obesity & Metabolism|February 2, 2021
Frequency, clinical features, inflammatory cytokines and genetic background of latent autoimmune diabetes in youth in youth-onset type 2 diabetes: Results from a nationwide, multicentre, clinic-based, cross-sectional study (LADA China)Yufei Xiang, Bingwen Liu, Chuan Yun, et al.
Cell Reports|June 23, 2022
Superimmunity by pan-sarbecovirus nanobodiesYufei Xiang, Wei Huang, Hejun Liu, et al.
Nature Communications|October 10, 2018
ROS-induced R loops trigger a transcription-coupled but BRCA1/2-independent homologous recombination pathway through CSBYaqun Teng, Tribhuwan Yadav, Meihan Duan, et al.
Cell Reports|July 2, 2025
Superimmunity by pan-sarbecovirus nanobodiesYufei Xiang, Wei Huang, Hejun Liu, et al.
Diabetes Care|October 23, 2014
Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3)Lingjiao Liu, Xia Li, Yufei Xiang, et al.
Iscience|September 15, 2021
A resource of high-quality and versatile nanobodies for drug deliveryZhuolun Shen, Yufei Xiang, Sandra Vergara, et al.
Signal Transduction and Targeted Therapy|April 19, 2023
Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trialXiang Yan, Xia Li, Bingwen Liu, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|April 8, 2022
GAD65 Antibody Epitopes and Genetic Background in Latent Autoimmune Diabetes in Youth (LADY)Yiman Peng, Xia Li, Yufei Xiang, et al.
Science Advances|May 27, 2021
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low dosesSham Nambulli, Yufei Xiang, Natasha L Tilston-Lunel, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low dosesSham Nambulli, Yufei Xiang, Natasha L Tilston-Lunel, et al.
Diabetes, Obesity & Metabolism|February 2, 2021
Frequency, clinical features, inflammatory cytokines and genetic background of latent autoimmune diabetes in youth in youth-onset type 2 diabetes: Results from a nationwide, multicentre, clinic-based, cross-sectional study (LADA China)Yufei Xiang, Bingwen Liu, Chuan Yun, et al.
Cell Reports|June 23, 2022
Superimmunity by pan-sarbecovirus nanobodiesYufei Xiang, Wei Huang, Hejun Liu, et al.
Nature Communications|October 10, 2018
ROS-induced R loops trigger a transcription-coupled but BRCA1/2-independent homologous recombination pathway through CSBYaqun Teng, Tribhuwan Yadav, Meihan Duan, et al.
Cell Reports|July 2, 2025
Superimmunity by pan-sarbecovirus nanobodiesYufei Xiang, Wei Huang, Hejun Liu, et al.
Diabetes Care|October 23, 2014
Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3)Lingjiao Liu, Xia Li, Yufei Xiang, et al.
Iscience|September 15, 2021
A resource of high-quality and versatile nanobodies for drug deliveryZhuolun Shen, Yufei Xiang, Sandra Vergara, et al.
Signal Transduction and Targeted Therapy|April 19, 2023
Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trialXiang Yan, Xia Li, Bingwen Liu, et al.
Pageof 9